Can inflammation shift zinc and other minerals into tissues and make plasma levels look low?

Systemic inflammation significantly alters how the body distributes essential minerals, frequently confounding standard nutritional blood panels by depressing circulating levels.

Cellular redistribution mechanisms

• Cytokine-driven import: Inflammatory cytokines, particularly interleukin-6 (IL-6) and interleukin-1β (IL-1β), robustly upregulate the expression of the cell-surface zinc importer ZIP14 (SLC39A14) on hepatocytes.
• Intracellular sequestration: ZIP14 acts as an influx channel, rapidly moving zinc from extracellular fluid and plasma into the liver and cellular compartments, producing transient hypozincemia.
• Antioxidant buffering: This intracellular influx activates metal-regulatory transcription factor-1 (MTF-1), which drives the transcription of metallothioneins. These proteins buffer free zinc, protecting host cells from oxidative and nitrosative stress while supporting vital immune-cell defenses.

Clinical biomarker implications

• Confounded blood panels: Because zinc is sequestered into tissues during the acute-phase response, plasma zinc levels exhibit a strong, documented inverse relationship with C-reactive protein (CRP).
• Magnesium suppression: Lower serum magnesium levels are also independently associated with elevated high-sensitivity CRP during states of chronic low-grade inflammation.
• False deficiency readings: Consequently, standard blood tests can falsely present mineral status as marginal or deficient during active immune activation, even when total body stores are entirely adequate.

Bottom line

• Standard plasma mineral panels are highly sensitive to inflammatory tone, often mimicking deficiency states by sequestering zinc and magnesium into tissues.
• To avoid misdiagnosing nutritional deficiencies, clinicians must concurrently measure and interpret inflammatory biomarkers like CRP alongside circulating mineral levels.